Sodium Potassium Chloride Symporter Inhibitors
"Sodium Potassium Chloride Symporter Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.
| Descriptor ID |
D049994
|
| MeSH Number(s) |
D27.505.519.562.906 D27.505.696.560.500.931
|
| Concept/Terms |
Sodium Potassium Chloride Symporter Inhibitors- Sodium Potassium Chloride Symporter Inhibitors
- Na-K-CL Symporter Inhibitors
- Inhibitors, Na-K-CL Symporter
- Na K CL Symporter Inhibitors
- Symporter Inhibitors, Na-K-CL
- Sodium Potassium Chloride Cotransporter Inhibitors
- Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors
- Bumetanide Sensitive Na K Cl Transporter Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Sodium Potassium Chloride Symporter Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Sodium Potassium Chloride Symporter Inhibitors".
This graph shows the total number of publications written about "Sodium Potassium Chloride Symporter Inhibitors" by people in this website by year, and whether "Sodium Potassium Chloride Symporter Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sodium Potassium Chloride Symporter Inhibitors" by people in Profiles.
-
Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY, Grodin JL, Gupta D, Margulies KB, LaRue S, Dávila-Román VG, Hernandez AF, de Las Fuentes L. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. J Card Fail. 2018 Jul; 24(7):428-438.
-
Khazanie P, Hammill BG, Patel CB, Kiernan MS, Cooper LB, Arnold SV, Fendler TJ, Spertus JA, Curtis LH, Hernandez AF. Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. J Card Fail. 2016 Sep; 22(9):672-9.
-
Corapi KM, Wenger JB, Bhan I. Blood pressure and serum parathyroid hormone level--reply. JAMA Intern Med. 2015 Jun; 175(6):1069-70.
-
Corapi KM, McMahon GM, Wenger JB, Seifter JL, Bhan I. Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function. JAMA Intern Med. 2015 Jan; 175(1):137-8.
-
Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, Sheng Duh M, Lefebvre P. Quality measure attainment in patients with type 2 diabetes mellitus. Am J Manag Care. 2014 Jan; 20(1 Suppl):s5-15.
-
Freda BJ, Slawsky M, Mallidi J, Braden GL. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis. 2011 Dec; 58(6):1005-17.
-
Wertheimer EV, Salicioni AM, Liu W, Trevino CL, Chavez J, Hernández-González EO, Darszon A, Visconti PE. Chloride Is essential for capacitation and for the capacitation-associated increase in tyrosine phosphorylation. J Biol Chem. 2008 Dec 19; 283(51):35539-50.
-
Smithline HA. Acute decompensated heart failure. CMAJ. 2007 Jul 17; 177(2):175; author reply 175-6.